Patients With Chronic HBV Treated With Entecavir, Tenofovir Disoproxil Fumarate Have Low HBsAg Seroclearance, Study Finds

June 24, 2021

Infectious Disease Advisor (6/23, Aghjayan), says “Patients with chronic hepatitis B virus (HBV) infection who are treated with entecavir or tenofovir disoproxil fumarate have been found to have low seroclearance of hepatitis B surface antigen (HBsAg),” a...